Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4652 - 4658
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
INFECTIONS | CANDIDA-ALBICANS | THERAPY | TESTING SUSCEPTIBILITIES | MICRODILUTION METHOD | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AGENTS | AMPHOTERICIN-B | ITRACONAZOLE | EPIDEMIOLOGY | ASPERGILLUS | Fluconazole - pharmacology | Pseudallescheria - drug effects | Lipopeptides - pharmacology | Humans | Scedosporium - drug effects | Fusarium - drug effects | Paecilomyces - drug effects | Itraconazole - pharmacology | Microbial Sensitivity Tests | Voriconazole | Antifungal Agents - toxicity | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Aminopyridines - toxicity | Cell Line | Fungi - drug effects | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Yeasts - drug effects | Aspergillus - drug effects | Isoxazoles - pharmacology | Triazoles - pharmacology | Aminopyridines - pharmacology | Candida - drug effects | Isoxazoles - toxicity | Index Medicus | Toxicity | Antifungal agents | Molds | Cytotoxicity | Fungi | Infection | Antifungal activity | fluconazole | Amphotericin B | Minimum inhibitory concentration | micafungin | Itraconazole | Susceptibility
INFECTIONS | CANDIDA-ALBICANS | THERAPY | TESTING SUSCEPTIBILITIES | MICRODILUTION METHOD | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | AGENTS | AMPHOTERICIN-B | ITRACONAZOLE | EPIDEMIOLOGY | ASPERGILLUS | Fluconazole - pharmacology | Pseudallescheria - drug effects | Lipopeptides - pharmacology | Humans | Scedosporium - drug effects | Fusarium - drug effects | Paecilomyces - drug effects | Itraconazole - pharmacology | Microbial Sensitivity Tests | Voriconazole | Antifungal Agents - toxicity | Echinocandins - pharmacology | Antifungal Agents - pharmacology | Aminopyridines - toxicity | Cell Line | Fungi - drug effects | Amphotericin B - pharmacology | Pyrimidines - pharmacology | Yeasts - drug effects | Aspergillus - drug effects | Isoxazoles - pharmacology | Triazoles - pharmacology | Aminopyridines - pharmacology | Candida - drug effects | Isoxazoles - toxicity | Index Medicus | Toxicity | Antifungal agents | Molds | Cytotoxicity | Fungi | Infection | Antifungal activity | fluconazole | Amphotericin B | Minimum inhibitory concentration | micafungin | Itraconazole | Susceptibility
Journal Article
PLoS ONE, ISSN 1932-6203, 02/2014, Volume 9, Issue 2, p. e88319
Although mesenchymal stem cells (MSCs) can be obtained from the fetal membrane (FM), little information is available regarding biological differences in MSCs...
RESPONSES | REPAIR | MARROW | MULTIDISCIPLINARY SCIENCES | PLACENTA | ISCHEMIA | STROMAL CELLS | TRANSPLANTATION | Myocytes, Cardiac - cytology | Amnion - cytology | Humans | Ischemia - therapy | Male | Mesenchymal Stromal Cells - secretion | Chorion - cytology | Immunosuppression | Mesenchymal Stromal Cells - cytology | Animals | Hindlimb - blood supply | Mice, Nude | Human Umbilical Vein Endothelial Cells - cytology | Hindlimb - pathology | Female | Mice | Intercellular Signaling Peptides and Proteins - secretion | Mesenchymal Stem Cell Transplantation | Neovascularization, Physiologic | Cytoprotection | Cell death | Prostaglandins E | Stem cells | Fibroblast growth factors | Comparative analysis | Vascular endothelial growth factor | Health aspects | Graft-versus-host reaction | Heart attacks | Transplants & implants | Mesenchyme | Insulin-like growth factor I | Prostaglandin E2 | Transplantation | Lymphocytes T | Insulin-like growth factors | Capillary flow | Biochemistry | Adipocytes | Cell surface | Regeneration (physiology) | Angiogenesis | Allografts | Ischemia | Rodents | Bone marrow | Conditioning | Fibroblast growth factor 2 | Starvation | Hematology | Internal medicine | Tissue engineering | Secretion | Fetuses | Cloning | Cardiomyocytes | Chorion | Endothelial cells | Blood flow | Medicine | Regeneration | Placenta | Skin & tissue grafts | Amnion | Hypoxia | Umbilical cord | Diabetes | Laboratory animals
RESPONSES | REPAIR | MARROW | MULTIDISCIPLINARY SCIENCES | PLACENTA | ISCHEMIA | STROMAL CELLS | TRANSPLANTATION | Myocytes, Cardiac - cytology | Amnion - cytology | Humans | Ischemia - therapy | Male | Mesenchymal Stromal Cells - secretion | Chorion - cytology | Immunosuppression | Mesenchymal Stromal Cells - cytology | Animals | Hindlimb - blood supply | Mice, Nude | Human Umbilical Vein Endothelial Cells - cytology | Hindlimb - pathology | Female | Mice | Intercellular Signaling Peptides and Proteins - secretion | Mesenchymal Stem Cell Transplantation | Neovascularization, Physiologic | Cytoprotection | Cell death | Prostaglandins E | Stem cells | Fibroblast growth factors | Comparative analysis | Vascular endothelial growth factor | Health aspects | Graft-versus-host reaction | Heart attacks | Transplants & implants | Mesenchyme | Insulin-like growth factor I | Prostaglandin E2 | Transplantation | Lymphocytes T | Insulin-like growth factors | Capillary flow | Biochemistry | Adipocytes | Cell surface | Regeneration (physiology) | Angiogenesis | Allografts | Ischemia | Rodents | Bone marrow | Conditioning | Fibroblast growth factor 2 | Starvation | Hematology | Internal medicine | Tissue engineering | Secretion | Fetuses | Cloning | Cardiomyocytes | Chorion | Endothelial cells | Blood flow | Medicine | Regeneration | Placenta | Skin & tissue grafts | Amnion | Hypoxia | Umbilical cord | Diabetes | Laboratory animals
Journal Article
Immunity, ISSN 1074-7613, 08/2016, Volume 45, Issue 2, pp. 319 - 332
Interferon regulatory factor-5 (IRF5), a transcription factor critical for the induction of innate immune responses, contributes to the pathogenesis of the...
B-CELLS | PATHOGENESIS | IRF5(-/-) MICE | SYSTEMIC-LUPUS-ERYTHEMATOSUS | DENDRITIC CELLS | DISEASE | TOLL-LIKE RECEPTORS | DEFICIENT MICE | IMMUNOLOGY | INTERFERON REGULATORY FACTOR | I INTERFERON | Autoimmunity | Phosphorylation | Cytokines - metabolism | Signal Transduction | Dendritic Cells - immunology | Humans | Mice, Inbred C57BL | Transcriptional Activation | Cells, Cultured | Interferon Regulatory Factors - metabolism | Immune Tolerance | Interferon Regulatory Factors - genetics | NF-kappa B - metabolism | Immunity, Innate | Mice, Knockout | Ubiquitination | Animals | Lupus Erythematosus, Systemic - immunology | src-Family Kinases - metabolism | Protein Binding | Mice | Toll-Like Receptors - metabolism | src-Family Kinases - genetics | Myeloid Differentiation Factor 88 - metabolism | Lupus | Ubiquitin | Medical colleges | Systemic lupus erythematosus | Dendritic cells | Genetic aspects | Interferon | Genetic transcription | Biological response modifiers | Proteins | Studies | Statistical analysis | Disease | Cytokines | Genomes | Kinases | Autoimmune diseases | Gene expression
B-CELLS | PATHOGENESIS | IRF5(-/-) MICE | SYSTEMIC-LUPUS-ERYTHEMATOSUS | DENDRITIC CELLS | DISEASE | TOLL-LIKE RECEPTORS | DEFICIENT MICE | IMMUNOLOGY | INTERFERON REGULATORY FACTOR | I INTERFERON | Autoimmunity | Phosphorylation | Cytokines - metabolism | Signal Transduction | Dendritic Cells - immunology | Humans | Mice, Inbred C57BL | Transcriptional Activation | Cells, Cultured | Interferon Regulatory Factors - metabolism | Immune Tolerance | Interferon Regulatory Factors - genetics | NF-kappa B - metabolism | Immunity, Innate | Mice, Knockout | Ubiquitination | Animals | Lupus Erythematosus, Systemic - immunology | src-Family Kinases - metabolism | Protein Binding | Mice | Toll-Like Receptors - metabolism | src-Family Kinases - genetics | Myeloid Differentiation Factor 88 - metabolism | Lupus | Ubiquitin | Medical colleges | Systemic lupus erythematosus | Dendritic cells | Genetic aspects | Interferon | Genetic transcription | Biological response modifiers | Proteins | Studies | Statistical analysis | Disease | Cytokines | Genomes | Kinases | Autoimmune diseases | Gene expression
Journal Article
Vascular Cell, ISSN 2045-824X, 09/2014, Volume 6, Issue 1, pp. 18 - 18
Lenvatinib is an oral inhibitor of multiple receptor tyrosine kinases (RTKs) targeting vascular endothelial growth factor receptor (VEGFR1-3), fibroblast...
Lenvatinib | VEGFR2 kinase inhibitor | Microvessel density | Pericyte coverage | FGFR kinase inhibitor | Tyrosine | Liver cancer | Pancreatic cancer | Models | Fibroblast growth factors | Vascular endothelial growth factor | Endothelium | Angiogenesis | Thyroid cancer | Biomarkers | Cytotoxicity | Ligands | Breast cancer | Kinases | Cancer therapies | Tumors
Lenvatinib | VEGFR2 kinase inhibitor | Microvessel density | Pericyte coverage | FGFR kinase inhibitor | Tyrosine | Liver cancer | Pancreatic cancer | Models | Fibroblast growth factors | Vascular endothelial growth factor | Endothelium | Angiogenesis | Thyroid cancer | Biomarkers | Cytotoxicity | Ligands | Breast cancer | Kinases | Cancer therapies | Tumors
Journal Article
Antimicrobial Agents and Chemotherapy, ISSN 0066-4804, 10/2011, Volume 55, Issue 10, pp. 4543 - 4551
Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit...
CELL TRANSPLANT RECIPIENTS | CLINICAL-PRACTICE GUIDELINES | SURVEILLANCE NETWORK TRANSNET | IN-VITRO | OROPHARYNGEAL CANDIDIASIS | TRIAZOLE | MK-0991 L-743,872 | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INVASIVE FUNGAL-INFECTIONS | INFECTIOUS-DISEASES SOCIETY | EPIDEMIOLOGY | Aspergillus fumigatus - drug effects | Fusarium - drug effects | Candida tropicalis - drug effects | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candida albicans - drug effects | Aminopyridines - therapeutic use | Candidiasis - drug therapy | Fusariosis - drug therapy | Female | Aspergillosis - drug therapy | Antifungal Agents - pharmacology | Aminopyridines - administration & dosage | Aspergillus flavus - drug effects | Isoxazoles - administration & dosage | Mice, Inbred ICR | Isoxazoles - pharmacology | Animals | Aminopyridines - pharmacology | Aspergillosis - microbiology | Mice | Isoxazoles - therapeutic use | Antifungal Agents - administration & dosage | Fusariosis - microbiology | Animal models | Candidiasis | Lung | Data processing | Colony-forming cells | Survival | Infection | fluconazole | fusariosis | Amphotericin B | Aspergillosis | Caspofungin | Voriconazole | Glycosylphosphatidylinositol | Experimental Therapeutics
CELL TRANSPLANT RECIPIENTS | CLINICAL-PRACTICE GUIDELINES | SURVEILLANCE NETWORK TRANSNET | IN-VITRO | OROPHARYNGEAL CANDIDIASIS | TRIAZOLE | MK-0991 L-743,872 | MICROBIOLOGY | PHARMACOLOGY & PHARMACY | INVASIVE FUNGAL-INFECTIONS | INFECTIOUS-DISEASES SOCIETY | EPIDEMIOLOGY | Aspergillus fumigatus - drug effects | Fusarium - drug effects | Candida tropicalis - drug effects | Candidiasis - microbiology | Antifungal Agents - therapeutic use | Microbial Sensitivity Tests | Candida albicans - drug effects | Aminopyridines - therapeutic use | Candidiasis - drug therapy | Fusariosis - drug therapy | Female | Aspergillosis - drug therapy | Antifungal Agents - pharmacology | Aminopyridines - administration & dosage | Aspergillus flavus - drug effects | Isoxazoles - administration & dosage | Mice, Inbred ICR | Isoxazoles - pharmacology | Animals | Aminopyridines - pharmacology | Aspergillosis - microbiology | Mice | Isoxazoles - therapeutic use | Antifungal Agents - administration & dosage | Fusariosis - microbiology | Animal models | Candidiasis | Lung | Data processing | Colony-forming cells | Survival | Infection | fluconazole | fusariosis | Amphotericin B | Aspergillosis | Caspofungin | Voriconazole | Glycosylphosphatidylinositol | Experimental Therapeutics
Journal Article
Biomedical Research, ISSN 0388-6107, 2018, Volume 39, Issue 1, pp. 27 - 38
Severe fever with thrombocytopenia syndrome phlebovirus (SFTSV) is a newly emerged phlebovirus identified in China, Japan, and South Korea. Phlebovirus...
CYTOPLASMIC TAIL | MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | RETENTION SIGNAL | BUNYAMWERA-VIRUS | GLYCOPROTEINS | INFECTION | MATURATION | G(N) | CORONAVIRUS | BUNYAVIRUS | Thrombocytopenia | Structural proteins | Viruses | Confocal microscopy | Glycoproteins | RNA polymerase | DNA-directed RNA polymerase | RNA-directed RNA polymerase | Fever | Golgi apparatus | Proteins | Polymerase | Microscopy | Compartments | Hemagglutinins | Localization | Endoplasmic reticulum | Budding
CYTOPLASMIC TAIL | MEDICINE, RESEARCH & EXPERIMENTAL | LOCALIZATION | RETENTION SIGNAL | BUNYAMWERA-VIRUS | GLYCOPROTEINS | INFECTION | MATURATION | G(N) | CORONAVIRUS | BUNYAVIRUS | Thrombocytopenia | Structural proteins | Viruses | Confocal microscopy | Glycoproteins | RNA polymerase | DNA-directed RNA polymerase | RNA-directed RNA polymerase | Fever | Golgi apparatus | Proteins | Polymerase | Microscopy | Compartments | Hemagglutinins | Localization | Endoplasmic reticulum | Budding
Journal Article
Journal of Biological Chemistry, ISSN 0021-9258, 04/2004, Volume 279, Issue 18, pp. 18600 - 18607
c-kit receptor tyrosine kinase is a marker of progenitor cells, which differentiate into blood and/or vascular endothelial cells, and has an important role in...
PROGENITOR CELLS | MESSENGER-RNA | MAP KINASE | PHOSPHATIDYLINOSITOL 3-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MAST-CELLS | C-KIT | GROWTH-FACTOR | TUMOR ANGIOGENESIS | RECEPTOR TYROSINE KINASE | HEMATOPOIETIC PROGENITOR | Endothelium, Vascular - cytology | Proto-Oncogene Proteins - metabolism | Phosphorylation | Signal Transduction | Cell Survival | Humans | Protein-Serine-Threonine Kinases | Umbilical Veins | Capillaries - growth & development | Proto-Oncogene Proteins c-akt | Capillaries - cytology | Stem Cell Factor - physiology | Mitogen-Activated Protein Kinase 3 | Cell Movement | Mitogen-Activated Protein Kinase 1 - metabolism | Mitogen-Activated Protein Kinases - metabolism
PROGENITOR CELLS | MESSENGER-RNA | MAP KINASE | PHOSPHATIDYLINOSITOL 3-KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | MAST-CELLS | C-KIT | GROWTH-FACTOR | TUMOR ANGIOGENESIS | RECEPTOR TYROSINE KINASE | HEMATOPOIETIC PROGENITOR | Endothelium, Vascular - cytology | Proto-Oncogene Proteins - metabolism | Phosphorylation | Signal Transduction | Cell Survival | Humans | Protein-Serine-Threonine Kinases | Umbilical Veins | Capillaries - growth & development | Proto-Oncogene Proteins c-akt | Capillaries - cytology | Stem Cell Factor - physiology | Mitogen-Activated Protein Kinase 3 | Cell Movement | Mitogen-Activated Protein Kinase 1 - metabolism | Mitogen-Activated Protein Kinases - metabolism
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 5/2012, Volume 69, Issue 5, pp. 1353 - 1362
Indisulam (N-(-3-chloro-7-indolyl)-1,4-benzenedisulfonamide; E7070) is an experimental anticancer agent. Microarray analysis indicates that indisulam...
Indisulam | Isobologram analysis | SN-38 | Medicine & Public Health | Topoisomerase IIα | Cancer Research | Oncology | Pharmacology/Toxicology | SOLID TUMORS | CELL-CYCLE INHIBITOR | TOPOISOMERASE-II-ALPHA | EVERY 3 WEEKS | RESISTANT | ETOPOSIDE | ONCOLOGY | CAMPTOTHECIN | LINE | PHARMACOLOGY & PHARMACY | Topoisomerase II alpha | AGENTS | PHASE-I | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | DNA Topoisomerases, Type I - drug effects | Time Factors | Microarray Analysis | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Antigens, Neoplasm - genetics | DNA Topoisomerases, Type I - metabolism | DNA-Binding Proteins - drug effects | DNA-Binding Proteins - genetics | Blotting, Western | Drug Synergism | Up-Regulation - drug effects | Xenograft Model Antitumor Assays | Animals | DNA Topoisomerases, Type II - drug effects | Mice, Nude | Cell Line, Tumor | DNA Topoisomerases, Type II - genetics | Mice | Colorectal Neoplasms - pathology | Antigens, Neoplasm - drug effects | Sulfonamides - administration & dosage | Drugs | Care and treatment | Genes | Colorectal cancer | Drug resistance | Antineoplastic agents | Antimitotic agents | Metabolites | Sulfonamides | Analysis | Drug therapy | Health aspects | Tumors | Cancer | DNA topoisomerase (ATP-hydrolysing) | Antitumor agents | Molecular modelling | DNA topoisomerase | Antitumor activity | Cytotoxicity | Western blotting
Indisulam | Isobologram analysis | SN-38 | Medicine & Public Health | Topoisomerase IIα | Cancer Research | Oncology | Pharmacology/Toxicology | SOLID TUMORS | CELL-CYCLE INHIBITOR | TOPOISOMERASE-II-ALPHA | EVERY 3 WEEKS | RESISTANT | ETOPOSIDE | ONCOLOGY | CAMPTOTHECIN | LINE | PHARMACOLOGY & PHARMACY | Topoisomerase II alpha | AGENTS | PHASE-I | Antineoplastic Combined Chemotherapy Protocols - administration & dosage | Humans | Antineoplastic Combined Chemotherapy Protocols - pharmacology | Dose-Response Relationship, Drug | DNA Topoisomerases, Type I - drug effects | Time Factors | Microarray Analysis | Colorectal Neoplasms - drug therapy | Camptothecin - administration & dosage | Female | Camptothecin - analogs & derivatives | Antigens, Neoplasm - genetics | DNA Topoisomerases, Type I - metabolism | DNA-Binding Proteins - drug effects | DNA-Binding Proteins - genetics | Blotting, Western | Drug Synergism | Up-Regulation - drug effects | Xenograft Model Antitumor Assays | Animals | DNA Topoisomerases, Type II - drug effects | Mice, Nude | Cell Line, Tumor | DNA Topoisomerases, Type II - genetics | Mice | Colorectal Neoplasms - pathology | Antigens, Neoplasm - drug effects | Sulfonamides - administration & dosage | Drugs | Care and treatment | Genes | Colorectal cancer | Drug resistance | Antineoplastic agents | Antimitotic agents | Metabolites | Sulfonamides | Analysis | Drug therapy | Health aspects | Tumors | Cancer | DNA topoisomerase (ATP-hydrolysing) | Antitumor agents | Molecular modelling | DNA topoisomerase | Antitumor activity | Cytotoxicity | Western blotting
Journal Article
Journal of Human Genetics, ISSN 1434-5161, 6/2008, Volume 53, Issue 6, pp. 546 - 553
Variations in the fat-mass and obesity-associated gene (FTO) are associated with the obesity phenotype in many Caucasian populations. This association with the...
Human Genetics | Obesity | Neurosciences | Biomedicine | Immunology | Fat-mass and obesity-associated gene | Association | SNP | Cancer Research | Molecular Medicine | Japanese population | Cell Biology | POPULATION | association | fat-mass and obesity-associated gene | ADULT OBESITY | VARIANT | GENETICS & HEREDITY | BODY-MASS INDEX | WEIGHT | CHILDHOOD OBESITY | obesity | SINGLE-NUCLEOTIDE POLYMORPHISMS | FAT MASS | EPIDEMIOLOGY | GENOME-WIDE ASSOCIATION | Body Mass Index | Humans | Japan | Middle Aged | Asian Continental Ancestry Group - genetics | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | Genotype | Male | Obesity - genetics | Case-Control Studies | Linkage Disequilibrium | Obesity - pathology | Genetic Variation | Proteins - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Medical colleges | Proteolipids | Lipoproteins | Analysis | Physiological aspects | Genetic research | Genetic aspects | Blood lipoproteins | Original
Human Genetics | Obesity | Neurosciences | Biomedicine | Immunology | Fat-mass and obesity-associated gene | Association | SNP | Cancer Research | Molecular Medicine | Japanese population | Cell Biology | POPULATION | association | fat-mass and obesity-associated gene | ADULT OBESITY | VARIANT | GENETICS & HEREDITY | BODY-MASS INDEX | WEIGHT | CHILDHOOD OBESITY | obesity | SINGLE-NUCLEOTIDE POLYMORPHISMS | FAT MASS | EPIDEMIOLOGY | GENOME-WIDE ASSOCIATION | Body Mass Index | Humans | Japan | Middle Aged | Asian Continental Ancestry Group - genetics | Alpha-Ketoglutarate-Dependent Dioxygenase FTO | Genotype | Male | Obesity - genetics | Case-Control Studies | Linkage Disequilibrium | Obesity - pathology | Genetic Variation | Proteins - genetics | Adult | Female | Aged | Polymorphism, Single Nucleotide | Medical colleges | Proteolipids | Lipoproteins | Analysis | Physiological aspects | Genetic research | Genetic aspects | Blood lipoproteins | Original
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 10/2011, Volume 128, Issue 4, pp. 941 - 947
Background: Management of arm lymphedema following breast cancer treatment is challenging, and emphasis should be put on early diagnosis and prevention of...
BREAST-CANCER | FLUORESCENCE LYMPHOGRAPHY | SURGERY | UPPER-LIMB LYMPHEDEMA | RISK-FACTORS | LYMPHATICOVENULAR ANASTOMOSIS | NODE DISSECTION | CANCER-RELATED LYMPHEDEMA | RADIONUCLIDE LYMPHOSCINTIGRAPHY | WATER DISPLACEMENT | MICROSURGERY | Severity of Illness Index | Breast Neoplasms - surgery | Lymphedema - diagnostic imaging | Lymphedema - physiopathology | Coloring Agents | Humans | Middle Aged | Indocyanine Green | Mastectomy - methods | Lymphedema - etiology | Lymphography - methods | Breast Neoplasms - pathology | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Upper Extremity | Aged | Mastectomy - adverse effects | Retrospective Studies | Neoplasm Staging | Early Diagnosis | Postoperative Complications - diagnostic imaging | Cohort Studies
BREAST-CANCER | FLUORESCENCE LYMPHOGRAPHY | SURGERY | UPPER-LIMB LYMPHEDEMA | RISK-FACTORS | LYMPHATICOVENULAR ANASTOMOSIS | NODE DISSECTION | CANCER-RELATED LYMPHEDEMA | RADIONUCLIDE LYMPHOSCINTIGRAPHY | WATER DISPLACEMENT | MICROSURGERY | Severity of Illness Index | Breast Neoplasms - surgery | Lymphedema - diagnostic imaging | Lymphedema - physiopathology | Coloring Agents | Humans | Middle Aged | Indocyanine Green | Mastectomy - methods | Lymphedema - etiology | Lymphography - methods | Breast Neoplasms - pathology | Sensitivity and Specificity | Aged, 80 and over | Adult | Female | Upper Extremity | Aged | Mastectomy - adverse effects | Retrospective Studies | Neoplasm Staging | Early Diagnosis | Postoperative Complications - diagnostic imaging | Cohort Studies
Journal Article
Plastic and Reconstructive Surgery, ISSN 0032-1052, 10/2011, Volume 128, Issue 4, pp. 314E - 321E
Background: Early diagnosis and treatment are as important for management of secondary lymphedema following cancer treatment as in primary cancer treatment....
SURGERY | DIAGNOSIS | INTRAVASCULAR STENTING METHOD | MANAGEMENT | THERAPY | LYMPHATICOVENULAR ANASTOMOSIS | VOLUME | DISEASE | LYMPHOSCINTIGRAPHY | WATER DISPLACEMENT | CIRCUMFERENCE MEASUREMENT | Severity of Illness Index | Lymphedema - diagnostic imaging | Risk Assessment | Neoplasms - surgery | Coloring Agents | Humans | Middle Aged | Indocyanine Green | Male | Neoplasms - diagnosis | Lymphedema - etiology | Neoplasms - complications | Lymphography - methods | Sensitivity and Specificity | Lower Extremity | Adult | Female | Aged | Retrospective Studies | Lymphatic Vessels - diagnostic imaging | Early Diagnosis | Cohort Studies
SURGERY | DIAGNOSIS | INTRAVASCULAR STENTING METHOD | MANAGEMENT | THERAPY | LYMPHATICOVENULAR ANASTOMOSIS | VOLUME | DISEASE | LYMPHOSCINTIGRAPHY | WATER DISPLACEMENT | CIRCUMFERENCE MEASUREMENT | Severity of Illness Index | Lymphedema - diagnostic imaging | Risk Assessment | Neoplasms - surgery | Coloring Agents | Humans | Middle Aged | Indocyanine Green | Male | Neoplasms - diagnosis | Lymphedema - etiology | Neoplasms - complications | Lymphography - methods | Sensitivity and Specificity | Lower Extremity | Adult | Female | Aged | Retrospective Studies | Lymphatic Vessels - diagnostic imaging | Early Diagnosis | Cohort Studies
Journal Article
World Journal of Gastroenterology, ISSN 1007-9327, 05/2015, Volume 21, Issue 19, pp. 5985 - 5994
AIM: to evaluate the effectiveness of probiotic therapy for suppressing relapse in patients with inactive ulcerative colitis (UC). METHODS: Bio-Three tablets,...
Cluster analysis | Inflammatory bowel disease | Probiotics | Ulcerative colitis | GERMINATED BARLEY FOODSTUFF | SPONTANEOUS CONTRACTIONS | MAINTENANCE TREATMENT | FECAL MICROBIOTA | LENGTH-POLYMORPHISM ANALYSIS | MICROBIAL DIVERSITY | SODIUM-BUTYRATE | ENTERIC NERVES | MAINTAINING REMISSION | GASTROENTEROLOGY & HEPATOLOGY | COLONIC-MUCOSA | Recurrence | Humans | Middle Aged | Male | Chromatography, High Pressure Liquid | Feces - microbiology | Clostridium butyricum - genetics | Time Factors | Colitis, Ulcerative - therapy | Adult | Female | Bacillus - growth & development | Double-Blind Method | Enterococcus faecalis - genetics | Japan | Clostridium butyricum - growth & development | Kaplan-Meier Estimate | Treatment Outcome | Bacillus - genetics | Enterococcus faecalis - growth & development | Remission Induction | DNA, Bacterial - genetics | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - microbiology | Ribotyping | Probiotics - therapeutic use | Colon - microbiology | Cluster Analysis | Probiotics - adverse effects | Randomized Clinical Trial
Cluster analysis | Inflammatory bowel disease | Probiotics | Ulcerative colitis | GERMINATED BARLEY FOODSTUFF | SPONTANEOUS CONTRACTIONS | MAINTENANCE TREATMENT | FECAL MICROBIOTA | LENGTH-POLYMORPHISM ANALYSIS | MICROBIAL DIVERSITY | SODIUM-BUTYRATE | ENTERIC NERVES | MAINTAINING REMISSION | GASTROENTEROLOGY & HEPATOLOGY | COLONIC-MUCOSA | Recurrence | Humans | Middle Aged | Male | Chromatography, High Pressure Liquid | Feces - microbiology | Clostridium butyricum - genetics | Time Factors | Colitis, Ulcerative - therapy | Adult | Female | Bacillus - growth & development | Double-Blind Method | Enterococcus faecalis - genetics | Japan | Clostridium butyricum - growth & development | Kaplan-Meier Estimate | Treatment Outcome | Bacillus - genetics | Enterococcus faecalis - growth & development | Remission Induction | DNA, Bacterial - genetics | Colitis, Ulcerative - diagnosis | Colitis, Ulcerative - microbiology | Ribotyping | Probiotics - therapeutic use | Colon - microbiology | Cluster Analysis | Probiotics - adverse effects | Randomized Clinical Trial
Journal Article
PLoS ONE, ISSN 1932-6203, 12/2012, Volume 7, Issue 12, p. e53154
Obesity is associated with systemic low-grade inflammation and is a risk factor for non-alcoholic fatty pancreas disease (NAFPD), but the molecular mechanisms...
METABOLIC SYNDROME | OBESITY | ACTIVATION | INFLAMMATION | GHRELIN | MULTIDISCIPLINARY SCIENCES | STELLATE CELLS | ANTIINFLAMMATORY ROLE | IMMUNE FUNCTION | EXPRESSION | ADIPOSE-TISSUE | Severity of Illness Index | Obesity - complications | Pancreatitis - etiology | Mice, Inbred C57BL | Male | Pancreatic Diseases - prevention & control | Pancreatitis - prevention & control | Down-Regulation - drug effects | Spleen - surgery | Splenectomy - adverse effects | Interleukin-10 - physiology | Mice, Knockout | Obesity - metabolism | Pancreatic Diseases - pathology | Animals | Spleen - metabolism | Diet, High-Fat | Fibrosis - etiology | Interleukin-10 - metabolism | Obesity - etiology | Pancreatitis - pathology | Mice | Pancreatic Diseases - etiology | Interleukin-10 - pharmacology | Obesity | Interleukins | Diet | Pancreatitis | Hostages | Triglycerides | Inflammation | Pathogenesis | Interleukin | Macrophages | Experiments | Accumulation | Risk factors | High fat diet | Splenectomy | Quality | Rodents | Tumor necrosis factor-TNF | Trends | Pancreas | Deposition | Spleen | Carbohydrates | Liver diseases | Cytokines | Internal medicine | Health risks | Abdomen | Medicine | Molecular modelling | Interleukin 10 | Infiltration | Diabetes | Laboratory animals
METABOLIC SYNDROME | OBESITY | ACTIVATION | INFLAMMATION | GHRELIN | MULTIDISCIPLINARY SCIENCES | STELLATE CELLS | ANTIINFLAMMATORY ROLE | IMMUNE FUNCTION | EXPRESSION | ADIPOSE-TISSUE | Severity of Illness Index | Obesity - complications | Pancreatitis - etiology | Mice, Inbred C57BL | Male | Pancreatic Diseases - prevention & control | Pancreatitis - prevention & control | Down-Regulation - drug effects | Spleen - surgery | Splenectomy - adverse effects | Interleukin-10 - physiology | Mice, Knockout | Obesity - metabolism | Pancreatic Diseases - pathology | Animals | Spleen - metabolism | Diet, High-Fat | Fibrosis - etiology | Interleukin-10 - metabolism | Obesity - etiology | Pancreatitis - pathology | Mice | Pancreatic Diseases - etiology | Interleukin-10 - pharmacology | Obesity | Interleukins | Diet | Pancreatitis | Hostages | Triglycerides | Inflammation | Pathogenesis | Interleukin | Macrophages | Experiments | Accumulation | Risk factors | High fat diet | Splenectomy | Quality | Rodents | Tumor necrosis factor-TNF | Trends | Pancreas | Deposition | Spleen | Carbohydrates | Liver diseases | Cytokines | Internal medicine | Health risks | Abdomen | Medicine | Molecular modelling | Interleukin 10 | Infiltration | Diabetes | Laboratory animals
Journal Article
Current Medicinal Chemistry, ISSN 0929-8673, 2001, Volume 8, Issue 12, pp. 1487 - 1503
As a result of substantial advances in recent cancer biology, cell cycle regulation in the G1 phase has attracted a great deal of attention as a promising...
HISTONE DEACETYLASE INHIBITOR | CHEMISTRY, MEDICINAL | CDK-ACTIVATING KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHROMOBACTERIUM-VIOLACEUM NO-968 | TRANSCRIPTION FACTOR TFIIH | ANTITUMOR-ACTIVITY | FARNESYL-PROTEIN TRANSFERASE | DNA-DAMAGE CHECKPOINT | PHARMACOLOGY & PHARMACY | ANGIOGENESIS INHIBITOR TNP-470 | NF-KAPPA-B | UBIQUITIN-PROTEASOME PATHWAY | Neoplasms - metabolism | Antineoplastic Agents - pharmacology | Animals | G1 Phase - drug effects | Humans | Neoplasms - drug therapy
HISTONE DEACETYLASE INHIBITOR | CHEMISTRY, MEDICINAL | CDK-ACTIVATING KINASE | BIOCHEMISTRY & MOLECULAR BIOLOGY | CHROMOBACTERIUM-VIOLACEUM NO-968 | TRANSCRIPTION FACTOR TFIIH | ANTITUMOR-ACTIVITY | FARNESYL-PROTEIN TRANSFERASE | DNA-DAMAGE CHECKPOINT | PHARMACOLOGY & PHARMACY | ANGIOGENESIS INHIBITOR TNP-470 | NF-KAPPA-B | UBIQUITIN-PROTEASOME PATHWAY | Neoplasms - metabolism | Antineoplastic Agents - pharmacology | Animals | G1 Phase - drug effects | Humans | Neoplasms - drug therapy
Journal Article
Journal of Nippon Medical School, ISSN 1345-4676, 2017, Volume 84, Issue 5, pp. 224 - 230
Objective: The modified Glasgow Prognostic Score (mGPS) is an inflammation-based measure of malnutrition that reflects a state of cachexia in cancer patients....
surgical site infection (SSI) | modified Glasgow Prognostic Score (mGPS) | colorectal cancer surgery | Colorectal cancer surgery | Modified glasgow prognostic score (mGPS) | Surgical site infection (SSI) | C-REACTIVE PROTEIN | SYSTEMIC INFLAMMATION | MEDICINE, GENERAL & INTERNAL | IMPACT | RESECTION | COMPLICATIONS | GLASGOW PROGNOSTIC SCORE | OUTCOMES | CARCINOMA | Blood Loss, Surgical - statistics & numerical data | Colorectal Neoplasms - surgery | Predictive Value of Tests | Surgical Wound Infection - epidemiology | Prognosis | Humans | Middle Aged | Risk Factors | Glasgow Outcome Scale | Male | Cachexia | Surgical Wound Infection - etiology | Incidence | Nutrition Assessment | Operative Time | Colorectal Neoplasms - immunology | Aged, 80 and over | Adult | Female | Aged | Leukocyte Count | Retrospective Studies | Malnutrition | Preoperative Period
surgical site infection (SSI) | modified Glasgow Prognostic Score (mGPS) | colorectal cancer surgery | Colorectal cancer surgery | Modified glasgow prognostic score (mGPS) | Surgical site infection (SSI) | C-REACTIVE PROTEIN | SYSTEMIC INFLAMMATION | MEDICINE, GENERAL & INTERNAL | IMPACT | RESECTION | COMPLICATIONS | GLASGOW PROGNOSTIC SCORE | OUTCOMES | CARCINOMA | Blood Loss, Surgical - statistics & numerical data | Colorectal Neoplasms - surgery | Predictive Value of Tests | Surgical Wound Infection - epidemiology | Prognosis | Humans | Middle Aged | Risk Factors | Glasgow Outcome Scale | Male | Cachexia | Surgical Wound Infection - etiology | Incidence | Nutrition Assessment | Operative Time | Colorectal Neoplasms - immunology | Aged, 80 and over | Adult | Female | Aged | Leukocyte Count | Retrospective Studies | Malnutrition | Preoperative Period
Journal Article